Related references
Note: Only part of the references are listed.Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation
Monika Maciuszek et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential
Monika Maciuszek et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder
Enza Lacivita et al.
ACS CHEMICAL NEUROSCIENCE (2021)
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease
Ewa Trojan et al.
MOLECULAR NEUROBIOLOGY (2021)
Pro-resolving lipid mediator lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome
Claudio Derada Troletti et al.
CELL REPORTS (2021)
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures
Ewa Trojan et al.
CELLS (2021)
Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways
Kinga Tylek et al.
CELLS (2021)
Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling
Youwen Zhuang et al.
NATURE COMMUNICATIONS (2020)
Structural basis of ligand binding modes at the human formyl peptide receptor 2
Tong Chen et al.
NATURE COMMUNICATIONS (2020)
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure
Yoshikazu Asahina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function
Yi Yang et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology
Mauro Perretti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives
Margherita Mastromarino et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology
Jesmond Dalli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Substituted Pyridazin-3(2H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists
Girdhar Singh Deora et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Illuminating G-Protein-Coupling Selectivity of GPCRs
Asuka Inoue et al.
CELL (2019)
Comparison of affinity ranking using AutoDock-GPU and MM-GBSA scores for BACE-1 inhibitors in the D3R Grand Challenge 4
Lea El Khoury et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2019)
Resolvins as proresolving inflammatory mediators in cardiovascular disease
Xavier Capo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures
Joanna Slusarczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Sustainable Radical Cascades to Synthesize Difluoroalkylated Pyrrolo[1,2-a]indoles
Honggui Huang et al.
JOURNAL OF ORGANIC CHEMISTRY (2018)
Maresin 1 attenuates pro-inflammatory reactions and ER stress in HUVECs via PPAR alpha-mediated pathway
Tae Woo Jung et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation
Madia Letizia Stama et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
Cheng Xue Qin et al.
NATURE COMMUNICATIONS (2017)
Functional N-Formyl Peptide Receptor2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress
Madia L. Stama et al.
CHEMMEDCHEM (2017)
Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer
Maria Laura Pati et al.
BMC CANCER (2017)
被撤回的出版物: Anti-inflammatory properties of tianeptine on lipopolysaccharide-induced changes in microglial cells involve toll-like receptor-related pathways (Retracted article. See vol. 142, pg. 776, 2017)
Joanna Slusarczyk et al.
JOURNAL OF NEUROCHEMISTRY (2016)
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation
Monica Molteni et al.
MEDIATORS OF INFLAMMATION (2016)
Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
Mauro Perretti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells
Joanna Slusarczyk et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
FPR2/ALXR Agonists and the Resolution of Inflammation
Olivier Corminboeuf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists
Kenjiro Sato et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Lipoxin A4 methyl ester ameliorates cognitive deficits induced by chronic cerebral hypoperfusion through activating ERK/Nrf2 signaling pathway in rats
Wei Jin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4
Julien Hanson et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
Fabio Cattaneo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Learning and memory ... and the immune system
Ioana Marin et al.
LEARNING & MEMORY (2013)
The essential role for aromatic cluster in the β3 adrenergic receptor
Hai-yan Cai et al.
ACTA PHARMACOLOGICA SINICA (2012)
A Force Field with Discrete Displaceable Waters and Desolvation Entropy for Hydrated Ligand Docking
Stefano Forli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors
Igor A. Schepetkin et al.
MOLECULAR PHARMACOLOGY (2011)
What Formyl Peptide Receptors, if Any, Are Triggered by Compound 43 and Lipoxin A4?
H. Forsman et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1
Carine Aubry et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
R. D. Ye et al.
PHARMACOLOGICAL REVIEWS (2009)
Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9.: Part 2:: Isoindoline containing inhibitors
Sebastiaan Van Goethem et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Applications of high throughput microsomal stability assay in drug discovery
Li Di et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Effects of neurosteroids on hydrogen peroxide- and staurosporine-induced damage of human neuroblastoma SH-SY5Y cells
M. Leskiewicz et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils:: A novel mechanism for resolution of inflammation
Driss El Kebir et al.
JOURNAL OF IMMUNOLOGY (2007)
Resolution of inflammation: state of the art, definitions and terms
Charles N. Serhan et al.
FASEB JOURNAL (2007)
A novel mechanism of FK506-mediated neuroprotection: Downregulation of cytokine expression in glial cells
M Zawadzka et al.
GLIA (2005)
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
M Perretti et al.
NATURE MEDICINE (2002)
Lipid mediator class switching during acute inflammation: signals in resolution
BD Levy et al.
NATURE IMMUNOLOGY (2001)
Amyloid-β induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain
HL Tiffany et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu
JS Mills et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
